BCAL Diagnostics Health Care

$0.070 (0%)

High $0.08	Low $0.07	Trades 14	Turnover $24,276	Volume 333,655
30 June 2023 at 4:10pm

Register to track BDX and receive email alerts.

Market Cap (19-Sep) $26,913,880 (1,550th)	Close (30-Jun) $0.070 0 (0%)	Volume (30-Jun) 333,655	Shortsold (6-Jun) 304 (0.00%) (624th)
52w High $0.155	52w Low $0.052	P/E -	EPS -0.02

	Subject
	BDX BDX Article: BCAL Diagnostics closes oversubscribed raise; Ellerston tops up
	1 (current) 2 3
	BDX BDX Ann: Notification regarding unquoted securities - BDX
	BDX BDX Ann: Proposed issue of securities - BDX
	BDX BDX Ann: BCAL Findings Presented at ASCO Annual Meeting
	BDX BDX Ann: BCAL Appoints David Darling as Advisor
	BDX BDX Ann: Notification regarding unquoted securities - BDX
	BDX BDX Ann: Change of Director's Interest Notice
	BDX BDX Ann: BCAL Opens Development & Clinical Service Laboratory
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Half Yearly Report and Accounts
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Results of Meeting
	BDX BDX Ann: Results of Meeting
	BDX BDX Ann: BCAL AGM Presentation
	BDX BDX Ann: Shareholder Newsletter
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Letter to Shareholders on Annual General Meeting Notice
	BDX BDX Ann: Notice of Annual General Meeting/Proxy Form
	BDX BDX Ann: Establishment of Development & Clinical Service Laboratory
	BDX BDX Ann: Appendix 4G and Corporate Governance Statement
	BDX BDX Ann: Annual Report to shareholders
	BDX BDX Ann: Preliminary Final Report
	BDX BDX Ann: Application for quotation of securities - BDX
	BDX BDX Ann: Proposed issue of securities - BDX
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Change of Director's Interest Notice
	BDX BDX Ann: BCAL Enters US Product Development Agreement with Precion
	BDX BDX Ann: Change in substantial holding
	BDX BDX Ann: BCAL Presentation Accepted for 2022 ASCO Annual Meeting
	BDX BDX Ann: Application for quotation of securities - BDX
	BDX BDX Ann: BCAL to Present at NWR Virtual Investor Conference
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Shareholder Newsletter
	BDX BDX Article: Biotech CEOs hit the streets amid sector sell-off
	BDX BDX Ann: Change of Director's Interest Notice
	BDX BDX Ann: Appendix 4D & Interim Report
	BDX BDX Ann: Shares to be released from escrow
	BDX BDX Ann: 7 February Announcement - Additional Information
	BDX BDX Ann: Recent Analysis Significantly Improves Commercial Prospects
	BDX BDX Ann: Appendix 4C Revised
	BDX BDX Ann: Becoming a substantial holder
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Dr John Hurrell Appointed Chief Executive Officer
	BDX BDX Ann: Application for quotation of securities - BDX
	BDX BDX Ann: Change In Directors Interest Notice - Correction
	BDX BDX Ann: Directors Change of Interest Notice X 2
	BDX BDX Ann: Results of Meeting
	BDX BDX Ann: Results of Meeting
	BDX BDX Ann: AGM Presentation
	BDX BDX Ann: Addendum to Appendix 4C

Register to track BDX and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.07	580,702	+0.01 (15.00%)
12-Sep	$0.06	1	0.00 (4.76%)
11-Sep	$0.06	70,290	+0.01 (12.50%)
05-Sep	$0.06	87,665	0.00 (8.20%)
04-Sep	$0.06	258,993	0.00 (3.17%)
03-Sep	$0.06	127,127	+0.00 (6.78%)
29-Aug	$0.06	192,870	-0.01 (7.81%)
28-Aug	$0.06	58,465	+0.01 (23.08%)
22-Aug	$0.05	214,459	0.00 (5.45%)
21-Aug	$0.06	60,000	0.00 (8.33%)
15-Aug	$0.06	166,666	0.00 (0.00%)
14-Aug	$0.06	172,212	0.00 (3.23%)
07-Aug	$0.06	164,375	+0.00 (6.90%)
31-Jul	$0.06	195,003	0.00 (3.33%)
30-Jul	$0.06	374,201	-0.01 (9.09%)
5 up, 9 down, and 1 flat days